Redmond Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Redmond Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-13,166	Closed	-$464K	–	142
2015 Q1	$464K	Buy	13,166 +120	+0.9%	+$4.06K	0.23%	103
2014 Q4	$419K	Buy	13,046 +200	+2%	+$5.78K	0.21%	106
2014 Q3	$360K	Sell	12,846 -12,481	-49%	-$380K	0.19%	118
2014 Q2	$765K	Sell	25,327 -555	-2%	-$15.3K	0.37%	78
2014 Q1	$716K	Buy	25,882 +416	+2%	+$10.9K	0.38%	82
2013 Q4	$650K	Sell	25,466 -345	-1%	-$10.6K	0.35%	86
2013 Q3	$771K	Buy	25,811 +10,275	+66%	+$286K	0.45%	72
2013 Q2	$447K	Buy	+15,536	New	+$428K	0.33%	76

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Redmond Asset Management's BRLI Position: Q2 2015 in Review

Redmond Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 13,166 shares — an estimated $464K sold.

Redmond Asset Management first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $771K in Q3 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Redmond Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
Redmond Asset Management sold 13,166 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $464K.
Redmond Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Redmond Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $771K in Q3 2013.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Redmond Asset Management's 13F filing for Q2 2015, filed 13 Aug 2015.